U.S. federal trademark · Serial No. 99493141
Scientific research for the development of autoimmune disease and cancer therapeutics; development services in the nature of platform technology development, namely, development of immunotherapy platforms for the development of autoimmune disease and cancer therapeutics; development of pharmaceutical preparations for the treatment of autoimmune disease and cancer; development of platform technology, namely, development of immunotherapy platforms for manufacturing autoimmune disease and cancer therapeutics; scientific research in the field of antibody engineering for analytical and clinical purposes; antibody bioengineering in the nature of development of antibodies for analytical and clinical purposes
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.